Clinical Trial Update: Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describing characteristics and treatment of anosmia and ageusia after SARS-CoV-2 infection; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-covid-19 Persistent Smell and Taste Disorders

Snippet

Sponsor: Sherifa Ahmed Hamed | Conditions: Post-covid-19 Persistent Smell and Taste Disorders | Phase 4 | Status: COMPLETED